Neogen | NEOG - Operating Profit


Neogen reported $3.1M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Agilent USD 399M 46M Mar/2026
Bio-Rad Laboratories USD 72.6M 38.5M Jun/2026
Cerus USD -1.45M 488K Dec/2024
Danaher USD 1.13B 217M Jun/2026
Idexx Laboratories USD 425.57M 62.98M Jun/2026
Illumina USD 260M 21M Jun/2026
Integra LifeSciences USD 41.29M 29.82M Jun/2026
Neogen USD 3.1M 6.4M Mar/2026
OraSure Technologies USD -13.59M 2.13M Dec/2025
Pacific Biosciences Of California USD -53.19M 35.08M Dec/2025
Quidel USD -31.8M 5.5M Mar/2026
Rockwell Medical USD 515K 1.84M Jun/2024
STAAR Surgical USD 17.4M 28.34M Mar/2026
Thermo Fisher Scientific USD 2.18B 273M Jun/2026
Utah Medical Products USD 2.56M 124K Mar/2026
Zoetis USD 865M 30M Mar/2026